Lipoprotein (a) and its position among other risk factors of atherosclerosis

• Published in: Physiological research Vol. 57; no. 5; pp. 777 - 784
• Main Authors: Zlatohlávek, L, Zídková, K, Vrablík, M, Haas, T, Prusíková, M, Svobodová, H, Češka, R
• Format: Journal Article
• Language: English
• Published: Czech Republic Institute of Physiology 01.01.2008
• Subjects: Adult; Aged; Angioplasty; Apoprotein(a) - blood; Apoprotein(a) - genetics; Biomarkers - blood; Cardiovascular disease; Cholesterol; Conflicts of interest; Coronary Artery Disease - etiology; Coronary Artery Disease - genetics; Coronary Artery Disease - metabolism; Coronary Disease - etiology; Coronary Disease - genetics; Coronary Disease - metabolism; Diabetes Mellitus, Type 2 - complications; Female; Genes; Heart attacks; Humans; Hypertension - complications; Lipids - blood; Lipoprotein(a) - blood; Lipoprotein(a) - genetics; Male; Medical imaging; Metabolic syndrome; Middle Aged; Overweight - complications; Patients; Plasma; Polymorphism, Genetic; Promoter Regions, Genetic; Proteins; Risk Assessment; Risk Factors; Sample size; Smoking - adverse effects; Teaching hospitals; Up-Regulation
• ISSN: 0862-8408; 1802-9973
• DOI: 10.33549/physiolres.931133

Lipoprotein(a) [Lp(a)] comprises of an LDL particle and apolipoprotein(a) [apo(a)] and its elevated levels are considered a risk factor for atherosclerosis. The aim of our study was to find out whether elevated Lp(a) levels are associated with increased risk of atherosclerosis in patients with multiple other risk factors. We further tested the association of three polymorphisms of the apo(a) gene promoter with Lp(a) levels. No significant correlation was detected between Lp(a) levels and lipid and clinical parameters tested. The study demonstrated a significantly (p=0.0219) elevated Lp(a) level (mean 28±35 mg/dl, median 0.14) in patients with coronary heart disease (CHD). In a group with premature CHD the correlation was not significant anymore. There was a significant correlation between polymorphic loci of the promoter region of apo(a) gene and Lp(a) levels (+93C>T, p=0.0166, STR, p<0.0001). Our study suggests that elevated Lp(a) level is an independent risk factor of CHD in carriers of other important CHD risk factors. Observed association of sequence variants of the promoter of apo(a) gene with Lp(a) levels is caused in part due to linkage to a restricted range of apo(a) gene length isoforms.